Seo Young Oh, Yong Moon Lee, Dong Joo Kang, Hyeong Ju Kwon, Sabyasachi Chakraborty, Jae Hyun Park
{"title":"Breaking Barriers in Thyroid Cytopathology: Harnessing Deep Learning for Accurate Diagnosis.","authors":"Seo Young Oh, Yong Moon Lee, Dong Joo Kang, Hyeong Ju Kwon, Sabyasachi Chakraborty, Jae Hyun Park","doi":"10.3390/bioengineering12030293","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We address the application of artificial intelligence (AI) techniques in thyroid cytopathology, specifically for diagnosing papillary thyroid carcinoma (PTC), the most common type of thyroid cancer.</p><p><strong>Methods: </strong>Our research introduces deep learning frameworks that analyze cytological images from fine-needle aspiration cytology (FNAC), a key preoperative diagnostic method for PTC. The first framework is a patch-level classifier referred as \"TCS-CNN\", based on a convolutional neural network (CNN) architecture, to predict thyroid cancer based on the Bethesda System (TBS) category. The second framework is an attention-based deep multiple instance learning (AD-MIL) model, which employs a feature extractor using TCS-CNN and an attention mechanism to aggregate features from smaller-patch-level regions into predictions for larger-patch-level regions, referred to as bag-level predictions in this context.</p><p><strong>Results: </strong>The proposed TCS-CNN framework achieves an accuracy of 97% and a recall of 96% for small-patch-level classification, accurately capturing local malignancy information. Additionally, the AD-MIL framework also achieves approximately 96% accuracy and recall, demonstrating that this framework can maintain comparable performance while expanding the diagnostic coverage to larger regions through patch aggregation.</p><p><strong>Conclusions: </strong>This study provides a feasibility analysis for thyroid cytopathology classification and visual interpretability for AI diagnosis, suggesting potential improvements in patient outcomes and reductions in healthcare costs.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 3","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11939565/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12030293","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: We address the application of artificial intelligence (AI) techniques in thyroid cytopathology, specifically for diagnosing papillary thyroid carcinoma (PTC), the most common type of thyroid cancer.
Methods: Our research introduces deep learning frameworks that analyze cytological images from fine-needle aspiration cytology (FNAC), a key preoperative diagnostic method for PTC. The first framework is a patch-level classifier referred as "TCS-CNN", based on a convolutional neural network (CNN) architecture, to predict thyroid cancer based on the Bethesda System (TBS) category. The second framework is an attention-based deep multiple instance learning (AD-MIL) model, which employs a feature extractor using TCS-CNN and an attention mechanism to aggregate features from smaller-patch-level regions into predictions for larger-patch-level regions, referred to as bag-level predictions in this context.
Results: The proposed TCS-CNN framework achieves an accuracy of 97% and a recall of 96% for small-patch-level classification, accurately capturing local malignancy information. Additionally, the AD-MIL framework also achieves approximately 96% accuracy and recall, demonstrating that this framework can maintain comparable performance while expanding the diagnostic coverage to larger regions through patch aggregation.
Conclusions: This study provides a feasibility analysis for thyroid cytopathology classification and visual interpretability for AI diagnosis, suggesting potential improvements in patient outcomes and reductions in healthcare costs.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering